Pricing Log in Create free account

Clene Inc. (CLNN) vs Corbus Pharmaceuticals Holdings, Inc. (CRBP)

Clene Inc. and Corbus Pharmaceuticals Holdings, Inc. are both Biotechnology companies. Clene Inc. and Corbus Pharmaceuticals Holdings, Inc. are of similar size ($56.4M and $55.3M). Clene Inc. grew revenue faster over the last twelve months: 11.2% against −73.7%. Corbus Pharmaceuticals Holdings, Inc. has the higher net margin (0.00% vs −11,271.4%) and the higher return on invested capital (0.00% vs 0.00%). Across the 16 metrics below, Clene Inc. leads on 9 and Corbus Pharmaceuticals Holdings, Inc. on 7.

Valuation

Metric CLNN CRBP Biotechnology median
P/E n/m n/m 10.60
P/S 211.59 38.44 9.40
P/B n/m 0.58 2.13
Price to free cash flow n/m n/m 25.18
EV/EBITDA n/m 0.34 0.66
EV/Sales 196.34 (23.77) 9.02
Earnings yield (61.06%) (202.95%) (32.88%)
Free cash flow yield (33.01%) (146.45%) (23.13%)

Profitability

Metric CLNN CRBP Biotechnology median
Gross margin 68.49% 0.00% 68.51%
Operating margin (8,928.57%) 0.00% 0.00%
Net margin (11,271.43%) 0.00% 0.00%
Free cash flow margin (6,984.45%) 0.00% 0.00%
Return on equity 197.50% (95.58%) (51.96%)
Return on assets (120.65%) (80.85%) (46.06%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric CLNN CRBP Biotechnology median
Revenue growth (TTM) 11.21% (73.69%) 6.76%
EPS growth (last fiscal year) 53.26% (60.33%) 29.88%
Revenue growth, 5-year CAGR (0.59%) (14.34%) 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric CLNN CRBP Biotechnology median
Debt to equity (0.42) 0.00 0.00
Current ratio 0.85 5.71 4.97
Net debt to EBITDA (0.39) 1.90 1.01

Dividend

Metric CLNN CRBP Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric CLNN CRBP Biotechnology median
Market cap 56.43m 55.32m 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack